Key result
Aspirin reduces the risk for major cardiovascular events by approximately 25% in high-risk individuals.
Why the study?
Does aspirin prevent major cardiovascular events in people with type 2 diabetes?
Population
People with type 2 diabetes
Design
Review
Authors
Loading...
Supports aspirin consideration in high-risk T2D; leaves open confirmation in contemporary cohorts.
Does aspirin prevent major cardiovascular events in people with type 2 diabetes?
The text reviews the mechanistic rationale and historical evidence for using aspirin to prevent cardiovascular events, particularly in patients with type 2 diabetes who exhibit increased platelet reactivity.
John A. Colwell (2003) conducted a review in Cardiovascular disease in diabetes. Aspirin was evaluated. Aspirin reduces the risk for major cardiovascular events by approximately 25% in high-risk individuals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: